Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
News

Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr

The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024

  • By IPP Bureau | May 04, 2024

Ajanta Pharma Limited has reported Consolidated financial results for the period ended March 31, 2024.

Ajanta Pharma Limited has posted net profit of Rs. 202.72 crores for the period ended March 31, 2024 as against net profit of Rs. 210.03 crores for the period ended December 31, 2023. The company posted net profit Rs.122.25 crores for the period ended March 31, 2023.

The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024 as compared to Rs. 1,118.74 crores during the period ended December 31, 2023. The company reported total income of to Rs.918.67 crores during the period ended March 31, 2023.

For the Financial Year ended March 31, 2024, Ajanta Pharma has reported total income of Rs. 4,293.31 crores as compared to Rs. 3,841.28 crores during the Financial Year ended March 31, 2023.

Ajanta Pharma Limited has posted net profit of Rs.816.17 crores for the Financial Year ended March 31, 2024 as against net profit of Rs.587.98 crores for the Financial Year ended March 31, 2023.

Upcoming E-conference

Other Related stories

Startup

Digitization